References
Appel D, Freeman K. Clonidine helps cigarette smokers stop smoking. American Review of Respiratory Diseases 135: A354, 1987
Carney RM, Rich MW, TeVelde A, Saini J, Clark K, et al. The relationship between heart rate, heart rate variability and depression in patients with coronary heart disease. Journal of Psychosomatic Research 31: 4981, 1988
Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Contemporary Psychiatry, in press, 1990
Davison R, Kaplan K, Fintel D, Parker M, Anderson L, et al. The effect of clonidine on the cessation of cigarette smoking. Clinical Pharmacology and Therapeutics 44: 266–267, 1988
Edwards NB, Simmons RC, Rosenthal TL, Hoon P, Downs J. Doxepin in the treatment of nicotine withdrawal. Psychosomatics 29: 203–206, 1988
Fagerstrom OV. Efficacy of nicotine chewing gum: a review. In Pomerleau & Pomerleau (Eds) Nicotine replacement: a critical evaluation, Liss Inc, New York, 1988
Ferno O, Lichtneckert S, Lundgren C. A substitute for tobacco smoking. Psychopharmacologia 31: 201–204, 1973
Franks P, Harp J, Bell B. Randomized controlled trial of clonidine for smoking cessation in a primary care setting. Journal of the American Medical Association 262: 3011–3013, 1989
Gawin F, Compton M, Byck R. Potential use of buspirone as treatment for smoking cessation: a preliminary trial. Family Practice Recertification 11 (Suppl.): 74–78, 1989
Glassman AH, Covey LS, Stetner F. Smoking cessation, depression, and antidepressants. Abstract. 142nd Annual Meeting of the American Psychiatric Association, 1989
Glassman AH, Jackson WK, Walsh BT, Roose S, Rosenfeld B, et al. Cigarette craving, smoking withdrawal, and clonidine. Science 226: 864–866, 1984
Glassman AH, Stetner F, Walsh BT, Raizman P, Fleiss J. Clonidine, smoking cessation, and heavy smokers. Journal of the American Medical Association 259: 2863–2866, 1988
Hajek P, Jackson P, Belcher M. Long-term use of nicotine chewing gum. Journal of the American Medical Association 260: 1593–1596, 1988
Hall SM, Turnstall DG, Benowitz NL, Jones RT. Nicotine gum and behavioral treatment: a placebo controlled trial. Journal of Consulting and Clinical Psychology 55: 603–605, 1987
Henningfield J. How tobacco produces drug dependence. In The pharmacologic treatment of tobacco dependence: Proceedings of the World Congress, Harvard University Institute for the Study of Smoking Behavior and Policy, Cambridge, MA, 1985
Hjalmarson AM. Effect of nicotine chewing gum in smoking cessation: a randomized placebo-controlled double-blind study. Journal of the American Medical Association 252: 2835–2838, 1985
Hughes J. Clonidine, depression and smoking cessation. Journal of the American Medical Association 259: 2901, 1988
Hughes JR, Gust SW, Keenan RM, Fenwick JW, Healey ML. Nicotine vs placebo gum in general medical practice. Journal of the American Medical Association 261: 1300–1305, 1989
Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 43: 289–294, 1986
Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren L. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry 143: 993–997, 1986a
Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, et al. Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology 83: 82–87, 1984
Hughes J, Hatsukami D, Skoog K. Physical dependence on nicotine in gum: a placebo substitution trial. Journal of the American Medical Association 255: 3277–3279, 1986b
Jarvis MJ, Raw M, Russell MH, Feyerabend C. Randomized controlled trial of nicotine chewing gum. British Medical Journal 285: 537–540, 1982
Kandel DB, Davies M. Adult sequelae of adolescent depressive symptoms. Archives of General Psychiatry 43: 255–262, 1986
Lam W, Sacks HS, Sze PC, Chalmers TC. Meta-analysis of randomized controlled trials of nicotine chewing gum. Lancet 2: 27–30, 1987
Mohiuddin SM, Malesker M, Delcore MG, Sketch SR, Hilleman DE. Double-blind placebo-controlled evaluation of transdermal clonidine in smoking cessation. Chest 96 (Suppl): 208, 1989
Pomerleau OF, Adkins DM, Pertschuk M. Predictors of outcome and recidivism in smoking-cessation treatment. Addictive Behaviors 3: 65–70, 1978
Schacter S. Pharmacological and psychological determinants of smoking. Annals of Internal Medicine 88: 104–114, 1978
Schneider NG, Jarvik ME. Nicotine gum vs placebo gum: comparisons of withdrawal symptoms and success rates. In Grabowski & Hall (Eds) Pharmacological adjuncts in smoking cessation, NIDA Monograph Series 5, US Government Printing Office, Washington DC, 1985
Schwartz JL. Review and evaluation of smoking cessation methods: the United States and Canada, 1978–1985, US DHHS Public Health Service, NIH Publication No. 87-2940, US Government Printing Office, Washington, D.C., 1987
Svensson CK. Clinical pharmacokinetics of nicotine. Clinical Pharmacokinetics 12: 30–40, 1987
Troyer RJ, Markle GE. Cigarettes: the battle over smoking, Rutgers University Press, Brunswick, NJ, 1983
USDHEW. The health consequences of smoking, cardiovascular disease, a report of the Surgeon General, 1983, Public Health Service Publication No. 84-50204, Roekville, MD, 1984
USDHHS. The health consequences of smoking, nicotine addiction: a report of the Surgeon General, 1988, Public Health Service Publication No. (CDC) 88-8046, Rockville, MD, 1988
Wei H, Young D. Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms. British Journal of Addictions 83: 1221–1226, 1988
West RJ, Russell MH. Dependence on nicotine chewing gum. Journal of the American Medical Association 256: 3214–3215, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glassman, A.H., Covey, L.S. Future Trends in the Pharmacological Treatment of Smoking Cessation. Drugs 40, 1–5 (1990). https://doi.org/10.2165/00003495-199040010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199040010-00001